Immunovant, Inc. (IMVT) insider trading

By person

23 insiders · 298 transactions

11.3×

Eric Venker holds 11.3 times base salary in stock. $7.25M of shares against $636.62K in salary for 2026.

Salary from the company's own proxy. The shares are what Eric Venker last reported holding, valued at $28.50, the price Common Stock was last bought or sold at on the open market here, on 28 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Roivant Sciences Ltd. entity

Director

$774.94M (6)

—

+$774.94M

113,317,007

54.86%

$3.23B

+23,264%

Peter Salzmann

Chief Executive Officer

—

$12.74M (41)

−$12.74M

1,178,191

0.5704%

$33.58M

—

Roderick Wong

Chief Executive Officer

$9.27M (23)

—

+$9.27M

902,498

0.4369%

$25.72M

—

Andrew J. Fromkin

Director

$43.45K (1)

$8.60M (9) scheduled

−$8.56M

74,382

0.0360%

$2.12M

—

Eva Renee Barnett

Chief Financial Officer

—

$3.07M (33)

−$3.07M

396,774

0.1921%

$11.31M

—

Jay S Stout

Chief Technology Officer

—

$3.06M (26)

−$3.06M

198,937

0.0963%

$5.67M

—

Julia G. Butchko

Chief Development Officer

$190.85K (1)

$2.72M (30)

−$2.53M

440,959

0.2135%

$12.57M

—

William L. Macias

Chief Medical Officer

—

$2.28M (35)

−$2.28M

357,353

0.1730%

$10.18M

—

Mark S. Levine

Chief Legal Officer

—

$2.10M (23)

−$2.10M

319,228

0.1546%

$9.10M

—

Melanie Gloria

Chief Operating Officer

—

$1.67M (15)

−$1.67M

217,060

0.1051%

$6.19M

—

Tiago Girao

Chief Financial Officer

—

$1.60M (4)

−$1.60M

234,192

0.1134%

$6.67M

—

Tuyl Christopher Van

Chief Legal Officer

—

$1.46M (11)

−$1.46M

175,218

0.0848%

$4.99M

—

Atul Pande

Director

$123.90K (2)

$1.14M (9) scheduled

−$1.01M

136,731

0.0662%

$3.90M

—

Michael Geffner

Chief Medical Officer

—

$978.32K (12)

−$978.32K

217,958

0.1055%

$6.21M

+118.0%

Eric Venker

Chief Executive Officer

—

$581.42K (4)

−$581.42K

257,075

0.1245%

$7.33M

—

George Migausky V

Director

$53.55K (1)

$504.57K (3) scheduled

−$451.02K

137,251

0.0664%

$3.91M

+586.3%

Douglas J. Hughes

Director

$150.36K (1)

$503.49K (3) scheduled

−$353.14K

134,653

0.0652%

$3.84M

—

Frank Torti

Director

$116.20K (1)

—

+$116.20K

1,009,228

0.4886%

$28.76M

—

Robert Graham Susman

Director

—

$67.98K (1) scheduled

−$67.98K

36,394

0.0176%

$1.04M

—

Rita Jain

Chief Medical Officer

—

129,365

0.0626%

$3.69M

—

Michael James Elliott

Chief Scientific Officer

—

97,600

0.0473%

$2.78M

—

Pamela Ann Connealy

Chief Financial Officer

—

46,200

0.0224%

$1.32M

—

Jake Bauer

Director

—

38,896

0.0188%

$1.11M

—

Immunovant, Inc.

What the insiders did Net buying

By person